Nikolaus Marx

54.4k total citations · 13 hit papers
530 papers, 20.8k citations indexed

About

Nikolaus Marx is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Nikolaus Marx has authored 530 papers receiving a total of 20.8k indexed citations (citations by other indexed papers that have themselves been cited), including 216 papers in Cardiology and Cardiovascular Medicine, 175 papers in Endocrinology, Diabetes and Metabolism and 139 papers in Surgery. Recurrent topics in Nikolaus Marx's work include Diabetes Treatment and Management (140 papers), Cardiovascular Function and Risk Factors (76 papers) and Cardiac Imaging and Diagnostics (62 papers). Nikolaus Marx is often cited by papers focused on Diabetes Treatment and Management (140 papers), Cardiovascular Function and Risk Factors (76 papers) and Cardiac Imaging and Diagnostics (62 papers). Nikolaus Marx collaborates with scholars based in Germany, United States and United Kingdom. Nikolaus Marx's co-authors include Peter Libby, Jorge Plutzky, Michael Lehrke, Joachim Jankowski, Michael Böhm, Galina K. Sukhova, Vinzenz Hombach, Jürgen Floege, Bart Staels and Danilo Fliser and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Nikolaus Marx

486 papers receiving 20.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties

2007 1.1k citations Nikolaus Marx et al. profile →
Cardiovascular Disease in Chronic Kidney Disease

2021 1.1k citations Joachim Jankowski, Jürgen Floege et al. Circulation profile →
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

2018 756 citations Julio Rosenstock, Vlado Perkovic et al. profile →
T-lymphocyte Infiltration in Visceral Adipose Tissue

2008 562 citations Nikolaus Marx et al. profile →
Peroxisome Proliferator-Activated Receptor Gamma Activators Inhibit Gene Expression and Migration in Human Vascular Smooth Muscle Cells

1998 514 citations Nikolaus Marx et al. Circulation Research profile →
PPARα Activators Inhibit Cytokine-Induced Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells

1999 504 citations Nikolaus Marx et al. Circulation profile →
Type 1 Diabetes Mellitus and Cardiovascular Disease

2014 394 citations Nikolaus Marx, Darren K. McGuire et al. Circulation profile →
Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes

2019 394 citations Julio Rosenstock, Steven E. Kahn et al. profile →
Empagliflozin Increases Cardiac Energy Production in Diabetes

2018 293 citations Subodh Verma, Michael Lehrke et al. profile →
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes

2022 258 citations Nikolaus Marx, Michael Lehrke et al. Circulation profile →
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status

2020 243 citations Stefan D. Anker, Javed Butler et al. Circulation profile →
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting

2020 241 citations Michael Lehrke, Nikolaus Marx et al. profile →
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes

2025 89 citations Darren K. McGuire, Nikolaus Marx et al. profile →

Peers

Nikolaus Marx

EDM

CCM

SURGE

EPIDE

Angelo Avogaro Italy

Hermann Haller Germany

Winfried März Germany

Casper G. Schalkwijk Netherlands

Ulrich Laufs Germany

Ton J. Rabelink Netherlands

Arnold von Eckardstein Switzerland

Hiromi Rakugi Japan

Muredach P. Reilly United States

Erik S.G. Stroes Netherlands

Angelo Avogaro Italy

Nikolaus Marx

6.6k ×1.0

8.1k ×1.3

EDM

3.3k ×0.6

CCM

4.4k ×1.0

SURGE

2.0k ×0.6

EPIDE

Citations per year, relative to Nikolaus Marx Nikolaus Marx (= 1×) peers Angelo Avogaro

Countries citing papers authored by Nikolaus Marx

Since Specialization

Citations

This map shows the geographic impact of Nikolaus Marx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolaus Marx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolaus Marx more than expected).

Fields of papers citing papers by Nikolaus Marx

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikolaus Marx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolaus Marx. The network helps show where Nikolaus Marx may publish in the future.

Co-authorship network of co-authors of Nikolaus Marx

This figure shows the co-authorship network connecting the top 25 collaborators of Nikolaus Marx. A scholar is included among the top collaborators of Nikolaus Marx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikolaus Marx. Nikolaus Marx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gong, Qiuhong, Robert L. Hanson, Jinping Wang, et al.. (2025). Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study. The Lancet Diabetes & Endocrinology. 14(2). 137–148. 1 indexed citations

Schuett, Katharina, David Z.I. Cherney, Joachim Jankowski, et al.. (2025). Cardiovascular disease in chronic kidney disease. European Heart Journal. 46(23). 2148–2160. 8 indexed citations

Noels, Heidi, Emiel P. C. van der Vorst, Sébastien Rubin, et al.. (2025). Renal-Cardiac Crosstalk in the Pathogenesis and Progression of Heart Failure. Circulation Research. 136(11). 1306–1334. 9 indexed citations

Spicher, Nicolai, et al.. (2025). Towards Artificial Intelligence-Based Decision Support for Large-Scale Screening for Atrial Fibrillation. IEEE Journal of Biomedical and Health Informatics. 29(10). 7633–7642. 2 indexed citations

Balfanz, Paul, Dirk Müller‐Wieland, Stephan Jonas, et al.. (2024). Monitoring individualized glucose levels predicts risk for bradycardia in type 2 diabetes patients with chronic kidney disease: a pilot study. Scientific Reports. 14(1). 30290–30290. 2 indexed citations

Siddiqi, Tariq Jamal, David Z.I. Cherney, Tazeen H. Jafar, et al.. (2024). Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions. Journal of the American Society of Nephrology. 36(2). 242–255. 4 indexed citations

Niederau, Christian, René H. Tolba, Joachim Jankowski, et al.. (2024). Xanthohumol: Anti-Inflammatory Effects in Mechanically Stimulated Periodontal Ligament Stem Cells. Biomedicines. 12(12). 2688–2688. 1 indexed citations

Marx, Nikolaus, Lars Rydén, Massimo Federici, et al.. (2024). Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction. European Heart Journal. 45(48). 5117–5126. 4 indexed citations

Frick, Michael, et al.. (2023). Procedural performance between two cryoballoon systems for ablation of atrial fibrillation depends on pulmonary vein anatomy. Journal of Arrhythmia. 39(3). 341–351. 6 indexed citations

10.

Marx, Nikolaus, John Deanfield, Sofia Gerward, et al.. (2023). Prevalence of systemic inflammation in individuals with atherosclerotic cardiovascular disease: baseline characteristics from the SELECT, SOUL and FLOW phase 3 trials of semaglutide. European Heart Journal. 44(Supplement_2). 2 indexed citations

11.

Rosenstock, Julio, Ahmed A. Kolkailah, Darren K. McGuire, et al.. (2023). Incident and recurrent hypoglycaemia with linagliptin and glimepiride over a median of 6 years in the CAROLINA cardiovascular outcome trial. Diabetes Obesity and Metabolism. 25(6). 1453–1463.

12.

Dar, M. Saeed, Christoph Wanner, Nikolaus Marx, et al.. (2023). Cardiovascular outcomes trial data from EMPA‐REG OUTCOME , CAROLINA and CARMELINA : Assessment of a novel staging system for type 2 diabetes. Diabetes Obesity and Metabolism. 25(5). 1372–1384. 1 indexed citations

13.

Cosentino, Francesco, Nikolaus Marx, & Subodh Verma. (2023). The year in cardiovascular medicine 2022: the top 10 papers in diabetes and metabolic disorders. European Heart Journal. 44(6). 448–451. 2 indexed citations

14.

Marx, Nikolaus, Christoph Wanner, Joachim Jankowski, et al.. (2023). Recurrent cardiovascular events in patients with type 2 diabetes and haemodialysis: analysis from the 4D Study. Clinical Kidney Journal. 16(10). 1612–1621.

15.

Schuett, Katharina, Nikolaus Marx, & Michael Lehrke. (2023). The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy. Circulation Research. 132(8). 902–914. 34 indexed citations

16.

Daher, Ayham, Tobias Müller, Nikolaus Marx, et al.. (2021). Effects of Transcatheter Mitral Valve Repair Using MitraClip® Device on Sleep Disordered Breathing in Patients with Mitral Valve Regurgitation. Journal of Clinical Medicine. 10(15). 3332–3332. 3 indexed citations

17.

Jankowski, Joachim, Jürgen Floege, Danilo Fliser, Michael Böhm, & Nikolaus Marx. (2021). Cardiovascular Disease in Chronic Kidney Disease. Circulation. 143(11). 1157–1172. 1066 indexed citations breakdown →

18.

Anker, Stefan D., Javed Butler, Gerasimos Filippatos, et al.. (2020). Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status. Circulation. 143(4). 337–349. 243 indexed citations breakdown →

19.

Dembek, Till A., Guido Kobbe, Markus Kollmann, et al.. (2020). Reliable Detection of Atrial Fibrillation with a Medical Wearable during Inpatient Conditions. Sensors. 20(19). 5517–5517. 12 indexed citations

20.

McGuire, Darren K., John H. Alexander, Odd Erik Johansen, et al.. (2019). Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA. Circulation. 139(3). 351–361. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact